FI822891A0 - Foerfarande foer framstaellning av nya guaninderivat - Google Patents

Foerfarande foer framstaellning av nya guaninderivat

Info

Publication number
FI822891A0
FI822891A0 FI822891A FI822891A FI822891A0 FI 822891 A0 FI822891 A0 FI 822891A0 FI 822891 A FI822891 A FI 822891A FI 822891 A FI822891 A FI 822891A FI 822891 A0 FI822891 A0 FI 822891A0
Authority
FI
Finland
Prior art keywords
guaninderivat
nya
foerfarande foer
foer framstaellning
fluoro
Prior art date
Application number
FI822891A
Other languages
English (en)
Other versions
FI68054C (fi
FI68054B (fi
FI822891L (fi
Inventor
Curt-Erik Hagberg
Karl Nils-Gunnar Johansson
Zsuzsanna Maria Ilona Kovacs
Goeran Bertil Stening
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI822891A0 publication Critical patent/FI822891A0/fi
Publication of FI822891L publication Critical patent/FI822891L/fi
Application granted granted Critical
Publication of FI68054B publication Critical patent/FI68054B/fi
Publication of FI68054C publication Critical patent/FI68054C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI822891A 1980-12-22 1982-08-19 Foerfarande foer framstaellning av nya guaninderivat FI68054C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8009040 1980-12-22
SE8009040 1980-12-22
PCT/SE1981/000389 WO1982002202A1 (en) 1980-12-22 1981-12-22 Novel derivatives of guanine
SE8100389 1981-12-22

Publications (4)

Publication Number Publication Date
FI822891A0 true FI822891A0 (fi) 1982-08-19
FI822891L FI822891L (fi) 1982-08-19
FI68054B FI68054B (fi) 1985-03-29
FI68054C FI68054C (fi) 1985-07-10

Family

ID=20342543

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822891A FI68054C (fi) 1980-12-22 1982-08-19 Foerfarande foer framstaellning av nya guaninderivat

Country Status (17)

Country Link
US (1) US4495190A (fi)
EP (1) EP0055239B1 (fi)
JP (1) JPS57501963A (fi)
AT (1) ATE20748T1 (fi)
AU (1) AU542373B2 (fi)
CA (1) CA1172633A (fi)
DE (1) DE3174948D1 (fi)
DK (1) DK148279C (fi)
FI (1) FI68054C (fi)
GR (1) GR76971B (fi)
IL (1) IL64501A (fi)
NO (1) NO822712L (fi)
NZ (1) NZ199334A (fi)
RO (1) RO85288B (fi)
SU (2) SU1272991A3 (fi)
WO (1) WO1982002202A1 (fi)
ZA (1) ZA818781B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4801710A (en) * 1984-10-26 1989-01-31 Merck & Co., Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
YU45690B (sh) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina
EP0193454A1 (en) * 1985-02-25 1986-09-03 Merck & Co. Inc. 8-Substituted-9-hydroxyalkyl and hydroxyalkoxymethyl-guanines and pharmaceutical compositions containing them
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
SK280313B6 (sk) * 1990-04-24 1999-11-08 �Stav Organick� Chemie A Biochemie Av �R N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
JP2939646B2 (ja) * 1990-07-17 1999-08-25 チッソ株式会社 ４―置換―２―ヒドロキシブタン酸エステルおよび製造法
US5874578A (en) * 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
US5525606A (en) 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
US6359114B1 (en) * 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
US7241890B2 (en) 2001-10-30 2007-07-10 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
EP1670802A4 (en) * 2003-09-18 2010-07-07 Conforma Therapeutics Corp NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF HSP90 PROTEIN
EP1869027A4 (en) * 2005-03-30 2010-06-23 Conforma Therapeutics Corp ALKYNYL-PYRROLOPYRIMIDINES AND CORRESPONDING ANALOGS AS HSP90 INHIBITORS
CN101257797B (zh) * 2005-06-14 2013-06-12 布里格姆·扬大学 嘌呤类化合物的选择性n-9糖基化的方法
WO2007035963A2 (en) * 2005-09-23 2007-03-29 Conforma Therapeutics Corporation Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
CN108912055B (zh) * 2018-08-20 2020-06-30 河南师范大学 一种合成抗病毒药物西多福韦中间体和布昔洛韦中间体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34188A (en) * 1969-04-09 1972-12-29 Seiyaku T Co 4-(9-adenyl)-2,3-dihydroxy butyric acid and the preparation thereof
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
CS199093B1 (en) * 1977-10-20 1980-07-31 Antonin Holy Antiviral agent
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds

Also Published As

Publication number Publication date
EP0055239A1 (en) 1982-06-30
DE3174948D1 (en) 1986-08-21
FI68054C (fi) 1985-07-10
CA1172633A (en) 1984-08-14
NO822712L (no) 1982-08-09
RO85288B (ro) 1984-11-30
DK148279C (da) 1986-02-17
SU1272991A3 (ru) 1986-11-23
ATE20748T1 (de) 1986-08-15
SU1272992A3 (ru) 1986-11-23
IL64501A0 (en) 1982-03-31
EP0055239B1 (en) 1986-07-16
WO1982002202A1 (en) 1982-07-08
AU7872181A (en) 1982-07-01
ZA818781B (en) 1982-11-24
AU542373B2 (en) 1985-02-21
FI68054B (fi) 1985-03-29
FI822891L (fi) 1982-08-19
RO85288A (ro) 1984-11-25
IL64501A (en) 1985-07-31
GR76971B (fi) 1984-09-04
US4495190A (en) 1985-01-22
DK148279B (da) 1985-05-28
DK369982A (da) 1982-08-18
NZ199334A (en) 1985-09-13
JPS57501963A (fi) 1982-11-04

Similar Documents

Publication Publication Date Title
FI822891A0 (fi) Foerfarande foer framstaellning av nya guaninderivat
SE8202961D0 (sv) Cefalosporinderivat och forfarande for deras framstellning
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
FI863565A (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
NO883074L (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
ATE18225T1 (de) Guanin-derivate.
ATE19632T1 (de) Guanin-derivate.
SE7702232L (sv) Forfarande for framstellning av substituerade 8-azapurinderivat
FR2421616A1 (fr) Nouveaux medicaments constitues de derives de l'acide o-aminobenzoique
SE8206128D0 (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
DK490781A (da) 5-phenyltetrazoner og deres fysiologisk taalelige salte fremgangsmaader til deres fremstilling og deres anvendelse som laegemidler
SE8202433L (sv) Linkomycin-3-(5'-ribonukleotider)lempade for behandling av protosoriska sjukdomar
DK0437645T3 (da) Imidazolylpropylguanidinderivat, fremgangsmåde til fremstilling deraf og lægemidler indeholdende denne forbindelse
FR2401923A1 (fr) Nouvelles octahydropyrazinopyrimidinones 2,3,4,7,8,9-substituees, procede de preparation de ces derives et leur application en tant que medicaments
NO159277C (no) 2,6-bis-halogenacylamino-benzo(1,2-d:5,4-d[)-bistiazol-derivater egnet som mellomprodukter for fremstilling av terapeutisk aktive 2,6-bisaminobinzo-(1,2-d:5,4-d[)bistiazol-derivater.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ASTRA LAEKEMEDEL AKTIEBOLAG